Real-World check: does zepzelca hold up for tough lung cancer?
NCT ID NCT06021483
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study is tracking 300 people with advanced small cell lung cancer who are taking the drug Zepzelca (lurbinectedin) after their first chemotherapy stopped working. Researchers want to see how well the drug shrinks tumors and what side effects occur in everyday hospital settings. The goal is to gather real-world evidence to support safe and effective use of this treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Zepzelca (lurbinectedin)
What this could lead to
If successful, this study could confirm how well Zepzelca works and how safe it is in everyday medical practice for people with advanced small cell lung cancer.
What could go wrong
This is an observational study, not a controlled trial, so results may be less reliable. It only includes people who have already failed one chemotherapy, so findings may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCLC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Seoul National University Boramae Medical Center
RECRUITINGSeoul, South Korea
Contact